November 30, 2023 2023 C-Path Neuroscience Annual Meeting C-Path’s 2023 Neuroscience Program Annual Meeting is set for Thursday, November 30 in Washington D.C. Bringing stakeholders....
November 30, 2023 Assessing asthma symptoms in children: qualitative research supporting the development of the Pediatric Asthma Diary-Child (PAD-C) and Pediatric Asthma Diary-Observer (PAD-O).
November 29, 2023 C-Path’s Translational Therapeutics Accelerator and Celdara Medical Announce Pipeline-focused MOU TUCSON, Ariz. and LEBANON, N.H., November 29, 2023 — Critical Path Institute’s (C-Path) Translational Therapeutics Accelerator
November 21, 2023 Successfully Navigating the Valley of Death: the Importance of Accelerators in Drug Discovery and Development
November 21, 2023 Use of Registries in Regulatory Decision Making The C-Path team is working to revolutionize the use of real-world data in sharing the future of medical product development in...
November 16, 2023 Poster: C-Path’s Translational Therapeutics Accelerator: A Unique Solution to Successfully Bridge the Valley of Death in Academic Drug Discovery and Development
November 16, 2023 eCOA Holds Annual Meeting in Denmark C-Path’s eCOA Consortium convened in Copenhagen, Denmark for its EU face-to-face meeting on Thursday, November 16. The eCOA...
November 16, 2023 VCP Disease(s), an Integrated Approach to Neurodegenerative Disorders In this webinar from Critical Path Institute’s Rare Disease Cures Accelerator-Data and Analytics Platform (RDCA-DAP), speake
November 9, 2023 C-Path’s Pioneering Neuroscience Workshop Transforms the Landscape of Neurological Disorder Therapies TUCSON, Ariz., Nov. 9, 2023 – Critical Path Institute (C-Path) is pleased to announce the release of a new peer-reviewed publica